Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag (v3.6.2), replacing the previous v3.6.0, indicating the study record has been updated.
    Difference
    0.1%
    Check dated 2026-06-26T23:48:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The newer version deletes several core study-record sections (Contacts/Locations, Study Status, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Oversight, Study Identification, Recruitment Status) that together define how the trial is conducted and presented.
    Difference
    11%
    Check dated 2026-06-19T23:01:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page adds quick-access links 'Check who can join' and 'Find Contact Information' and updates the revision label from v3.5.5 to v3.6.0, representing a small UI/branding update in the study history.
    Difference
    0.4%
    Check dated 2026-06-12T16:35:39.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4 in the record history, marking a new platform release. It does not alter trial data or study details.
    Difference
    0.1%
    Check dated 2026-06-05T11:47:22.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new ClinicalTrials.gov release rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T02:13:44.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's revision history shows a new version, v3.5.3, added to the records. This reflects a small system update rather than substantive changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T18:37:11.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.